INFECTIOUS DISEASES: Edited by Emily BlodgetMultidrug-resistant bacteria in lung transplantationDominguez, Fernando; Blodget, EmilyAuthor Information Division of Infectious Diseases, University of Southern California, Keck School of Medicine, Los Angeles, California, USA Correspondence to Emily Blodget, MD, Division of Infectious Diseases, University of Southern California, Keck School of Medicine, 2020 Zonal Avenue, IRD Room 436, Los Angeles, CA 90033, USA. Tel: +1 323 409 4444; fax: +1 323 226 7726; e-mail: firstname.lastname@example.org Current Opinion in Organ Transplantation: August 2020 - Volume 25 - Issue 4 - p 348-350 doi: 10.1097/MOT.0000000000000782 Buy Metrics Abstract Purpose of review The review of infections in lung transplantation is beyond the scope of this article as it is a comprehensive topic, however we aim to focus on infections with multidrug-resistant (MDR) microorganisms in this patient population. Recent findings New emerging clinical studies have provided data regarding outcomes in lung transplant recipients with MDR bacterial infections. Summary Isolation of MDR bacteria from lung donors preoperatively has not been associated with worse outcomes in recipients. Patients with cystic fibrosis colonized with MDR bacteria do not have increased 1 year mortality rates compared to those without MDR bacteria. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.